Simplex Trading’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
DCM
ACA
DTC
OCA
CC
Simplex Trading's DFTX Position: Q1 2026 in Review
Simplex Trading reduced its Definium Therapeutics (DFTX) stake by 15% in Q1 2026, selling an estimated $120K and leaving 41,156 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #2754.
Simplex Trading first reported a position in DFTX in Q2 2021 and has held it in 16 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.
- Simplex Trading held 41,156 shares of Definium Therapeutics worth $778K as of Q1 2026.
- Simplex Trading sold 7,070 Definium Therapeutics shares in Q1 2026, an estimated $120K.
- Definium Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2754 holding.
- Simplex Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 16 quarters since.
- 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.